Used primarily as a key intermediate in the synthesis of pharmaceuticals, particularly in the production of non-steroidal anti-inflammatory drugs (NSAIDs) and other bioactive molecules. Its structure allows for easy functionalization, making it valuable in medicinal chemistry for developing compounds with enhanced metabolic stability and binding affinity. The electron-withdrawing trifluoromethyl group improves lipophilicity and resistance to oxidation, which is beneficial in designing drugs with improved pharmacokinetic profiles. Also employed in the preparation of agrochemicals and specialty organic materials where fluorinated moieties contribute to increased activity or environmental stability.